 Pamela Peterson
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 65 | 2023 | 1959 | 6.120 |
Why?
| | Defibrillators, Implantable | 30 | 2022 | 279 | 5.070 |
Why?
| | Cardiac Resynchronization Therapy | 9 | 2022 | 39 | 3.110 |
Why?
| | Registries | 41 | 2023 | 1773 | 2.440 |
Why?
| | Death, Sudden, Cardiac | 15 | 2019 | 158 | 2.200 |
Why?
| | Ventricular Dysfunction, Left | 13 | 2023 | 363 | 2.190 |
Why?
| | Stroke Volume | 25 | 2023 | 508 | 2.140 |
Why?
| | Sexual Dysfunction, Physiological | 3 | 2021 | 60 | 2.120 |
Why?
| | Bradycardia | 3 | 2021 | 47 | 1.970 |
Why?
| | Atrial Fibrillation | 8 | 2022 | 314 | 1.930 |
Why?
| | Cancer Survivors | 4 | 2024 | 203 | 1.870 |
Why?
| | Hospitalization | 27 | 2023 | 1761 | 1.860 |
Why?
| | Primary Prevention | 12 | 2019 | 171 | 1.790 |
Why?
| | Cardiology | 15 | 2022 | 260 | 1.780 |
Why?
| | American Heart Association | 18 | 2022 | 266 | 1.770 |
Why?
| | Cardiovascular Diseases | 14 | 2022 | 1724 | 1.670 |
Why?
| | Aged | 88 | 2023 | 19299 | 1.330 |
Why?
| | United States | 70 | 2023 | 12338 | 1.310 |
Why?
| | Healthcare Disparities | 7 | 2021 | 486 | 1.300 |
Why?
| | Cardiac Conduction System Disease | 2 | 2018 | 4 | 1.300 |
Why?
| | Myocardial Infarction | 19 | 2018 | 930 | 1.280 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 100 | 1.280 |
Why?
| | Practice Guidelines as Topic | 17 | 2019 | 1403 | 1.250 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 10 | 2023 | 180 | 1.240 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2018 | 79 | 1.230 |
Why?
| | Cardiac Rehabilitation | 3 | 2023 | 33 | 1.130 |
Why?
| | Humans | 154 | 2024 | 115908 | 1.080 |
Why?
| | Adrenergic beta-Antagonists | 10 | 2023 | 293 | 1.040 |
Why?
| | Patient Readmission | 9 | 2018 | 607 | 1.040 |
Why?
| | Guideline Adherence | 12 | 2019 | 494 | 1.010 |
Why?
| | Practice Patterns, Physicians' | 11 | 2020 | 1177 | 0.960 |
Why?
| | Medicare | 17 | 2023 | 666 | 0.940 |
Why?
| | Surgeons | 3 | 2022 | 240 | 0.940 |
Why?
| | Male | 94 | 2023 | 56128 | 0.910 |
Why?
| | Ventricular Function, Left | 7 | 2021 | 468 | 0.900 |
Why?
| | Female | 95 | 2023 | 60086 | 0.870 |
Why?
| | Health Status Disparities | 3 | 2021 | 208 | 0.850 |
Why?
| | Secondary Prevention | 6 | 2017 | 223 | 0.840 |
Why?
| | Patient Discharge | 15 | 2023 | 770 | 0.830 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 90 | 0.810 |
Why?
| | Cardiac Resynchronization Therapy Devices | 3 | 2020 | 10 | 0.790 |
Why?
| | Middle Aged | 58 | 2022 | 27084 | 0.780 |
Why?
| | Operating Rooms | 1 | 2022 | 87 | 0.770 |
Why?
| | Anemia | 4 | 2020 | 144 | 0.770 |
Why?
| | Aged, 80 and over | 35 | 2021 | 6438 | 0.760 |
Why?
| | Angiotensin Receptor Antagonists | 11 | 2023 | 78 | 0.750 |
Why?
| | Anti-Arrhythmia Agents | 4 | 2022 | 103 | 0.720 |
Why?
| | Neoplasms | 4 | 2024 | 2112 | 0.680 |
Why?
| | Retrospective Studies | 31 | 2023 | 12616 | 0.670 |
Why?
| | Hospitals | 7 | 2021 | 581 | 0.660 |
Why?
| | Heart Block | 1 | 2018 | 37 | 0.640 |
Why?
| | Ventricular Function | 1 | 2018 | 57 | 0.620 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 20 | 0.620 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 20 | 0.620 |
Why?
| | Heart Conduction System | 1 | 2018 | 81 | 0.620 |
Why?
| | Risk Assessment | 15 | 2021 | 3004 | 0.620 |
Why?
| | Cardiologists | 1 | 2018 | 41 | 0.610 |
Why?
| | Social Determinants of Health | 1 | 2020 | 138 | 0.610 |
Why?
| | Birth Certificates | 1 | 2017 | 8 | 0.600 |
Why?
| | Medicaid | 3 | 2021 | 411 | 0.600 |
Why?
| | Patient Compliance | 4 | 2017 | 524 | 0.580 |
Why?
| | Decision Support Techniques | 5 | 2022 | 352 | 0.580 |
Why?
| | Clinical Decision-Making | 3 | 2018 | 275 | 0.570 |
Why?
| | Peripheral Arterial Disease | 1 | 2023 | 379 | 0.570 |
Why?
| | Pregnancy Trimester, First | 1 | 2017 | 129 | 0.570 |
Why?
| | Congresses as Topic | 1 | 2018 | 200 | 0.570 |
Why?
| | Appointments and Schedules | 1 | 2017 | 73 | 0.570 |
Why?
| | Aminobutyrates | 6 | 2023 | 32 | 0.560 |
Why?
| | Risk Factors | 28 | 2023 | 8714 | 0.560 |
Why?
| | Treatment Outcome | 26 | 2023 | 9166 | 0.540 |
Why?
| | Critical Care | 2 | 2018 | 476 | 0.540 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1090 | 0.540 |
Why?
| | Hospital Mortality | 7 | 2019 | 784 | 0.530 |
Why?
| | Advisory Committees | 8 | 2022 | 208 | 0.520 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 123 | 0.510 |
Why?
| | Reminder Systems | 1 | 2017 | 162 | 0.510 |
Why?
| | Age Factors | 11 | 2020 | 2912 | 0.510 |
Why?
| | Prenatal Care | 1 | 2017 | 257 | 0.500 |
Why?
| | Outpatients | 4 | 2021 | 328 | 0.500 |
Why?
| | Waiting Lists | 1 | 2017 | 223 | 0.500 |
Why?
| | Cohort Studies | 21 | 2019 | 4960 | 0.500 |
Why?
| | Decision Making | 7 | 2022 | 792 | 0.490 |
Why?
| | Quality of Health Care | 6 | 2012 | 578 | 0.490 |
Why?
| | Patient Participation | 4 | 2022 | 362 | 0.490 |
Why?
| | Medication Adherence | 7 | 2021 | 536 | 0.490 |
Why?
| | Hemoglobins | 3 | 2020 | 313 | 0.470 |
Why?
| | Electrocardiography | 7 | 2021 | 554 | 0.470 |
Why?
| | Health Status Indicators | 3 | 2015 | 155 | 0.460 |
Why?
| | Insurance Coverage | 3 | 2021 | 204 | 0.440 |
Why?
| | Heart | 4 | 2023 | 612 | 0.440 |
Why?
| | Health Literacy | 2 | 2014 | 166 | 0.420 |
Why?
| | Heart-Assist Devices | 1 | 2018 | 486 | 0.420 |
Why?
| | Electric Countershock | 3 | 2019 | 101 | 0.410 |
Why?
| | Diabetes Mellitus | 5 | 2023 | 906 | 0.410 |
Why?
| | Stress, Psychological | 1 | 2020 | 975 | 0.410 |
Why?
| | Inpatients | 3 | 2023 | 380 | 0.400 |
Why?
| | Coronary Artery Disease | 3 | 2013 | 611 | 0.400 |
Why?
| | Minority Groups | 2 | 2021 | 232 | 0.390 |
Why?
| | Acculturation | 1 | 2012 | 52 | 0.390 |
Why?
| | Valsartan | 5 | 2022 | 22 | 0.390 |
Why?
| | Health Services Accessibility | 1 | 2017 | 771 | 0.390 |
Why?
| | Health Status | 6 | 2012 | 733 | 0.390 |
Why?
| | Quality of Life | 12 | 2024 | 2392 | 0.380 |
Why?
| | Biphenyl Compounds | 5 | 2022 | 50 | 0.380 |
Why?
| | Time Factors | 15 | 2021 | 6186 | 0.380 |
Why?
| | Arrhythmias, Cardiac | 3 | 2019 | 275 | 0.370 |
Why?
| | Tetrazoles | 5 | 2023 | 32 | 0.370 |
Why?
| | Heart Transplantation | 1 | 2017 | 673 | 0.370 |
Why?
| | Coronary Disease | 3 | 2008 | 349 | 0.360 |
Why?
| | Young Adult | 8 | 2024 | 10518 | 0.340 |
Why?
| | Sex Factors | 8 | 2018 | 1741 | 0.340 |
Why?
| | Metformin | 2 | 2023 | 278 | 0.330 |
Why?
| | Text Messaging | 2 | 2021 | 154 | 0.330 |
Why?
| | Catheter Ablation | 1 | 2012 | 280 | 0.320 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2023 | 488 | 0.310 |
Why?
| | Physician-Patient Relations | 4 | 2021 | 466 | 0.310 |
Why?
| | Quality Improvement | 4 | 2021 | 956 | 0.300 |
Why?
| | Adult | 22 | 2022 | 30820 | 0.290 |
Why?
| | Neprilysin | 4 | 2021 | 47 | 0.290 |
Why?
| | Survivors | 2 | 2009 | 405 | 0.280 |
Why?
| | Cross-Sectional Studies | 11 | 2022 | 4449 | 0.280 |
Why?
| | Equipment Design | 4 | 2017 | 516 | 0.280 |
Why?
| | Ventricular Remodeling | 2 | 2018 | 225 | 0.280 |
Why?
| | Aftercare | 6 | 2023 | 187 | 0.280 |
Why?
| | Follow-Up Studies | 13 | 2021 | 4446 | 0.270 |
Why?
| | Exercise Tolerance | 1 | 2008 | 223 | 0.270 |
Why?
| | Qualitative Research | 3 | 2021 | 964 | 0.270 |
Why?
| | Social Support | 5 | 2014 | 541 | 0.260 |
Why?
| | Mineralocorticoid Receptor Antagonists | 3 | 2020 | 43 | 0.260 |
Why?
| | Kidney Diseases | 1 | 2009 | 355 | 0.260 |
Why?
| | Exercise Test | 4 | 2008 | 541 | 0.250 |
Why?
| | Self Care | 4 | 2018 | 354 | 0.250 |
Why?
| | Prone Position | 1 | 2005 | 27 | 0.250 |
Why?
| | Informed Consent | 2 | 2023 | 163 | 0.250 |
Why?
| | Supine Position | 1 | 2005 | 34 | 0.250 |
Why?
| | Insurance, Health | 2 | 2017 | 247 | 0.250 |
Why?
| | Cardiovascular Agents | 2 | 2017 | 125 | 0.250 |
Why?
| | Diabetes Complications | 1 | 2006 | 212 | 0.240 |
Why?
| | Survival Rate | 7 | 2019 | 1653 | 0.240 |
Why?
| | Evidence-Based Medicine | 4 | 2013 | 686 | 0.240 |
Why?
| | Heart Diseases | 1 | 2008 | 337 | 0.240 |
Why?
| | Survival Analysis | 6 | 2019 | 1221 | 0.240 |
Why?
| | Sex Characteristics | 1 | 2009 | 644 | 0.240 |
Why?
| | Artifacts | 1 | 2005 | 123 | 0.230 |
Why?
| | Quality Assurance, Health Care | 4 | 2010 | 319 | 0.230 |
Why?
| | Predictive Value of Tests | 7 | 2018 | 1817 | 0.230 |
Why?
| | Incidence | 6 | 2019 | 2333 | 0.230 |
Why?
| | Adolescent | 6 | 2024 | 17955 | 0.230 |
Why?
| | Heart Rate | 3 | 2019 | 698 | 0.230 |
Why?
| | Image Enhancement | 1 | 2005 | 175 | 0.230 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2021 | 29 | 0.220 |
Why?
| | Odds Ratio | 7 | 2017 | 969 | 0.220 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 79 | 0.220 |
Why?
| | Drug Combinations | 5 | 2022 | 288 | 0.220 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2020 | 1216 | 0.220 |
Why?
| | Cardiac Surgical Procedures | 4 | 2010 | 433 | 0.220 |
Why?
| | Glomerular Filtration Rate | 2 | 2021 | 605 | 0.220 |
Why?
| | Social Class | 2 | 2017 | 213 | 0.220 |
Why?
| | Risk | 3 | 2019 | 830 | 0.220 |
Why?
| | Atherectomy | 1 | 2023 | 33 | 0.220 |
Why?
| | Vascular Patency | 1 | 2023 | 98 | 0.210 |
Why?
| | Prognosis | 9 | 2022 | 3342 | 0.210 |
Why?
| | Popliteal Artery | 1 | 2023 | 59 | 0.210 |
Why?
| | Movement | 1 | 2005 | 246 | 0.210 |
Why?
| | Mortality | 4 | 2017 | 293 | 0.210 |
Why?
| | Colorado | 6 | 2017 | 4122 | 0.210 |
Why?
| | Disposable Equipment | 1 | 2022 | 15 | 0.210 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 58 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2022 | 18 | 0.210 |
Why?
| | Longitudinal Studies | 5 | 2018 | 2437 | 0.200 |
Why?
| | Refusal to Participate | 1 | 2021 | 6 | 0.200 |
Why?
| | Depression | 6 | 2012 | 1149 | 0.200 |
Why?
| | Adenoidectomy | 1 | 2022 | 60 | 0.200 |
Why?
| | Surveys and Questionnaires | 10 | 2022 | 4670 | 0.200 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2091 | 0.200 |
Why?
| | Exercise | 3 | 2009 | 1611 | 0.200 |
Why?
| | Linear Models | 5 | 2017 | 778 | 0.200 |
Why?
| | Multivariate Analysis | 11 | 2017 | 1444 | 0.200 |
Why?
| | Hospital Costs | 1 | 2022 | 106 | 0.200 |
Why?
| | Femoral Artery | 1 | 2023 | 168 | 0.200 |
Why?
| | Child | 6 | 2022 | 18555 | 0.200 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2021 | 53 | 0.190 |
Why?
| | Intensive Care Units | 2 | 2018 | 616 | 0.190 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 41 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 55 | 0.190 |
Why?
| | Comorbidity | 7 | 2023 | 1476 | 0.190 |
Why?
| | Interrupted Time Series Analysis | 1 | 2021 | 44 | 0.190 |
Why?
| | Prospective Studies | 11 | 2018 | 6267 | 0.190 |
Why?
| | Manufacturing Industry | 1 | 2020 | 4 | 0.190 |
Why?
| | Chi-Square Distribution | 5 | 2017 | 502 | 0.190 |
Why?
| | Clinical Trials as Topic | 4 | 2015 | 945 | 0.190 |
Why?
| | Patient Care | 1 | 2021 | 103 | 0.190 |
Why?
| | Prosthesis Implantation | 2 | 2019 | 139 | 0.180 |
Why?
| | Protease Inhibitors | 1 | 2021 | 102 | 0.180 |
Why?
| | Groundwater | 1 | 2021 | 33 | 0.180 |
Why?
| | Goals | 2 | 2020 | 159 | 0.180 |
Why?
| | Algorithms | 2 | 2021 | 1494 | 0.180 |
Why?
| | Confidence Intervals | 2 | 2012 | 310 | 0.180 |
Why?
| | Research Personnel | 1 | 2021 | 154 | 0.180 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 150 | 0.170 |
Why?
| | Hypertension | 3 | 2021 | 1063 | 0.170 |
Why?
| | Income | 1 | 2020 | 170 | 0.170 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2020 | 54 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 249 | 0.170 |
Why?
| | Multimorbidity | 1 | 2019 | 30 | 0.160 |
Why?
| | Logistic Models | 7 | 2015 | 1865 | 0.160 |
Why?
| | Personal Satisfaction | 1 | 2020 | 185 | 0.160 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 478 | 0.160 |
Why?
| | Antirheumatic Agents | 1 | 2021 | 255 | 0.160 |
Why?
| | Research Design | 2 | 2023 | 947 | 0.160 |
Why?
| | Societies, Medical | 3 | 2019 | 690 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 251 | 0.160 |
Why?
| | Fraud | 1 | 2018 | 8 | 0.160 |
Why?
| | Hospitals, Rural | 1 | 2018 | 31 | 0.160 |
Why?
| | Postoperative Complications | 1 | 2009 | 2167 | 0.150 |
Why?
| | Minority Health | 1 | 2018 | 20 | 0.150 |
Why?
| | Patient Selection | 4 | 2021 | 656 | 0.150 |
Why?
| | Medical Overuse | 1 | 2018 | 31 | 0.150 |
Why?
| | Computers, Handheld | 1 | 2018 | 24 | 0.150 |
Why?
| | Social Values | 1 | 2018 | 36 | 0.150 |
Why?
| | Bundle-Branch Block | 2 | 2017 | 26 | 0.150 |
Why?
| | Hospitals, Urban | 1 | 2018 | 129 | 0.150 |
Why?
| | Subacute Care | 1 | 2018 | 70 | 0.150 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 340 | 0.150 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 126 | 0.150 |
Why?
| | Treatment Refusal | 2 | 2008 | 84 | 0.150 |
Why?
| | Cause of Death | 3 | 2019 | 369 | 0.140 |
Why?
| | Prevalence | 5 | 2022 | 2270 | 0.140 |
Why?
| | Coronary Angiography | 3 | 2008 | 313 | 0.140 |
Why?
| | Prosthesis Design | 1 | 2018 | 290 | 0.140 |
Why?
| | Thromboembolism | 1 | 2017 | 93 | 0.140 |
Why?
| | Nurse Practitioners | 1 | 2018 | 104 | 0.140 |
Why?
| | Warfarin | 1 | 2017 | 136 | 0.140 |
Why?
| | Length of Stay | 2 | 2018 | 963 | 0.140 |
Why?
| | Publishing | 1 | 2018 | 126 | 0.140 |
Why?
| | Medically Uninsured | 1 | 2017 | 122 | 0.130 |
Why?
| | Proportional Hazards Models | 4 | 2019 | 1088 | 0.130 |
Why?
| | Racism | 1 | 2018 | 101 | 0.130 |
Why?
| | Quality Indicators, Health Care | 1 | 2018 | 285 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 230 | 0.130 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2021 | 440 | 0.130 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 990 | 0.120 |
Why?
| | Mental Health | 1 | 2020 | 573 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 332 | 0.120 |
Why?
| | Kidney | 1 | 2021 | 1208 | 0.120 |
Why?
| | Software | 1 | 2018 | 532 | 0.110 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 1193 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2018 | 712 | 0.110 |
Why?
| | Hyperkalemia | 1 | 2013 | 25 | 0.110 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2598 | 0.110 |
Why?
| | Systole | 2 | 2013 | 168 | 0.110 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 119 | 0.110 |
Why?
| | Anticoagulants | 1 | 2017 | 545 | 0.110 |
Why?
| | Hemodialysis Units, Hospital | 1 | 2012 | 5 | 0.110 |
Why?
| | Vascular Access Devices | 1 | 2012 | 24 | 0.110 |
Why?
| | Medical Staff | 1 | 2012 | 15 | 0.110 |
Why?
| | Physicians | 1 | 2020 | 774 | 0.100 |
Why?
| | Antihypertensive Agents | 2 | 2023 | 430 | 0.100 |
Why?
| | Communication | 1 | 2018 | 749 | 0.100 |
Why?
| | Evidence-Based Practice | 2 | 2013 | 190 | 0.100 |
Why?
| | Models, Educational | 1 | 2012 | 86 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 2 | 2016 | 819 | 0.100 |
Why?
| | Stroke | 2 | 2017 | 1014 | 0.100 |
Why?
| | Drug Prescriptions | 1 | 2013 | 241 | 0.100 |
Why?
| | Angina Pectoris | 2 | 2010 | 62 | 0.100 |
Why?
| | Vocabulary | 1 | 2011 | 41 | 0.100 |
Why?
| | Pilot Projects | 3 | 2021 | 1374 | 0.090 |
Why?
| | Bacteremia | 1 | 2012 | 159 | 0.090 |
Why?
| | Peripheral Vascular Diseases | 1 | 2011 | 98 | 0.090 |
Why?
| | Ambulatory Care Facilities | 1 | 2012 | 210 | 0.090 |
Why?
| | Managed Care Programs | 1 | 2011 | 135 | 0.090 |
Why?
| | Renin-Angiotensin System | 2 | 2023 | 72 | 0.090 |
Why?
| | Contraindications | 1 | 2010 | 85 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2012 | 390 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2015 | 475 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2009 | 2814 | 0.090 |
Why?
| | Women's Health Services | 1 | 2010 | 16 | 0.090 |
Why?
| | Palliative Care | 2 | 2019 | 643 | 0.090 |
Why?
| | Diuretics | 2 | 2020 | 67 | 0.090 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 374 | 0.080 |
Why?
| | Probability | 1 | 2010 | 297 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2012 | 480 | 0.080 |
Why?
| | ROC Curve | 1 | 2009 | 451 | 0.080 |
Why?
| | Coronary Care Units | 1 | 2007 | 13 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2011 | 339 | 0.080 |
Why?
| | Myocardial Reperfusion | 1 | 2007 | 51 | 0.080 |
Why?
| | Emergency Service, Hospital | 2 | 2010 | 1842 | 0.080 |
Why?
| | Caregivers | 1 | 2014 | 714 | 0.080 |
Why?
| | Women's Health | 1 | 2010 | 271 | 0.070 |
Why?
| | Chest Pain | 1 | 2007 | 82 | 0.070 |
Why?
| | Emotions | 1 | 2012 | 486 | 0.070 |
Why?
| | Health Personnel | 1 | 2012 | 578 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 647 | 0.070 |
Why?
| | Myocardial Ischemia | 2 | 2019 | 237 | 0.070 |
Why?
| | Research Report | 2 | 2017 | 76 | 0.070 |
Why?
| | Weight Loss | 2 | 2009 | 632 | 0.070 |
Why?
| | Angina, Unstable | 1 | 2006 | 72 | 0.070 |
Why?
| | Consensus | 2 | 2019 | 533 | 0.070 |
Why?
| | Syndrome | 1 | 2006 | 339 | 0.070 |
Why?
| | Pregnancy | 1 | 2017 | 5556 | 0.070 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 64 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2006 | 151 | 0.060 |
Why?
| | Physical Endurance | 1 | 2006 | 223 | 0.060 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 50 | 0.060 |
Why?
| | Radionuclide Imaging | 1 | 2005 | 121 | 0.060 |
Why?
| | Heart Valves | 1 | 2005 | 42 | 0.060 |
Why?
| | Recovery of Function | 1 | 2008 | 578 | 0.060 |
Why?
| | Electronic Health Records | 1 | 2011 | 801 | 0.060 |
Why?
| | Depressive Disorder | 1 | 2007 | 337 | 0.060 |
Why?
| | Weight Gain | 1 | 2007 | 455 | 0.060 |
Why?
| | Acute Disease | 1 | 2006 | 917 | 0.060 |
Why?
| | Overweight | 1 | 2007 | 468 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 219 | 0.050 |
Why?
| | Biomedical Research | 1 | 2008 | 590 | 0.050 |
Why?
| | Sodium | 1 | 2023 | 182 | 0.050 |
Why?
| | Patients | 1 | 2024 | 164 | 0.050 |
Why?
| | Medical Oncology | 1 | 2024 | 230 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2021 | 48 | 0.050 |
Why?
| | Adhesives | 1 | 2021 | 11 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2021 | 28 | 0.050 |
Why?
| | Disease Management | 2 | 2017 | 562 | 0.050 |
Why?
| | Population Health | 1 | 2021 | 45 | 0.050 |
Why?
| | Trust | 1 | 2021 | 108 | 0.050 |
Why?
| | Transferrins | 1 | 2020 | 1 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1728 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.040 |
Why?
| | Forecasting | 1 | 2022 | 332 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 40 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 429 | 0.040 |
Why?
| | Ferritins | 1 | 2020 | 57 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 325 | 0.040 |
Why?
| | Patient Safety | 2 | 2012 | 276 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 280 | 0.040 |
Why?
| | Aspirin | 2 | 2015 | 326 | 0.040 |
Why?
| | United States Government Agencies | 1 | 2018 | 6 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 545 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2010 | 540 | 0.040 |
Why?
| | Cardiovascular Nursing | 1 | 2018 | 3 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 904 | 0.040 |
Why?
| | Focus Groups | 1 | 2020 | 386 | 0.040 |
Why?
| | Transitional Care | 1 | 2018 | 37 | 0.040 |
Why?
| | Tachycardia, Ventricular | 1 | 2019 | 145 | 0.040 |
Why?
| | F Factor | 1 | 2017 | 3 | 0.040 |
Why?
| | Health Facility Size | 1 | 2017 | 12 | 0.040 |
Why?
| | Biomarkers | 2 | 2017 | 3474 | 0.040 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 254 | 0.040 |
Why?
| | Exercise Therapy | 1 | 2020 | 353 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 1868 | 0.040 |
Why?
| | Sex Distribution | 1 | 2017 | 338 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2017 | 102 | 0.040 |
Why?
| | Cerebrovascular Disorders | 1 | 2017 | 82 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2023 | 1008 | 0.030 |
Why?
| | Information Dissemination | 1 | 2018 | 192 | 0.030 |
Why?
| | Skilled Nursing Facilities | 1 | 2017 | 120 | 0.030 |
Why?
| | Administration, Oral | 1 | 2017 | 731 | 0.030 |
Why?
| | Frail Elderly | 1 | 2015 | 107 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1602 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 961 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2018 | 585 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 240 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3258 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1149 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1333 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 130 | 0.030 |
Why?
| | Potassium | 1 | 2013 | 128 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1486 | 0.030 |
Why?
| | Hemorrhage | 1 | 2017 | 616 | 0.030 |
Why?
| | Dementia | 1 | 2015 | 185 | 0.030 |
Why?
| | Propensity Score | 1 | 2014 | 225 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 374 | 0.030 |
Why?
| | Pacific States | 1 | 2012 | 7 | 0.030 |
Why?
| | New England | 1 | 2012 | 27 | 0.030 |
Why?
| | Needs Assessment | 1 | 2014 | 320 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2012 | 56 | 0.030 |
Why?
| | Health Maintenance Organizations | 1 | 2012 | 96 | 0.030 |
Why?
| | Recurrence | 1 | 2015 | 949 | 0.030 |
Why?
| | Creatinine | 1 | 2013 | 431 | 0.030 |
Why?
| | Education | 1 | 2012 | 99 | 0.030 |
Why?
| | History, 21st Century | 1 | 2012 | 164 | 0.020 |
Why?
| | Internationality | 1 | 2012 | 146 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2013 | 252 | 0.020 |
Why?
| | Infection Control | 1 | 2012 | 137 | 0.020 |
Why?
| | Drug Utilization | 1 | 2012 | 166 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 399 | 0.020 |
Why?
| | History, 20th Century | 1 | 2012 | 276 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5089 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2012 | 104 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 466 | 0.020 |
Why?
| | Lung Diseases | 1 | 2017 | 710 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 190 | 0.020 |
Why?
| | Poisson Distribution | 1 | 2010 | 72 | 0.020 |
Why?
| | Terminal Care | 1 | 2012 | 210 | 0.020 |
Why?
| | Renal Dialysis | 1 | 2012 | 371 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2009 | 61 | 0.020 |
Why?
| | Infant | 1 | 2021 | 8002 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 9175 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2008 | 67 | 0.020 |
Why?
| | Databases as Topic | 1 | 2007 | 62 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1115 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 2008 | 123 | 0.020 |
Why?
| | Reperfusion | 1 | 2006 | 40 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2009 | 234 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2010 | 647 | 0.020 |
Why?
| | Family | 1 | 2009 | 591 | 0.020 |
Why?
| | Clinical Competence | 1 | 2012 | 918 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2009 | 478 | 0.020 |
Why?
| | California | 1 | 2006 | 369 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2007 | 594 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2005 | 195 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2009 | 654 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 378 | 0.010 |
Why?
| | Anxiety | 1 | 2009 | 853 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2009 | 847 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1075 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1536 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 1826 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 1982 | 0.010 |
Why?
| | Obesity | 1 | 2007 | 2530 | 0.010 |
Why?
|
|
Peterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|